CRISPR Therapeutics AG (CRSP)

Last Closing Price: 38.93 (2026-11-19)

Total Liabilities (Quarterly)

Total Liabilities: The total value of all possible claims against the corporation.

CRISPR Therapeutics AG (CRSP) had Total Liabilities of $908.34M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$12.67M
$-111.44M
--
$12.67M
$142.71M
$-130.04M
$18.68M
$-111.36M
$-111.36M
$-111.44M
$-111.44M
$-111.44M
$-111.44M
$-130.04M
$-125.81M
96.74M
96.74M
$-1.15
$-1.15
Balance Sheet Financials
$2.29B
$104.30M
$271.33M
$2.56B
$140.96M
$586.93M
$767.38M
Total Liabilities
$908.34M
$1.65B
$1.65B
$1.65B
96.86M
Cash Flow Statement Financials
$-282.08M
$-480.49M
$603.54M
$359.08M
$200.03M
$-159.04M
$51.60M
--
--
Fundamental Metrics & Ratios
16.21
--
--
0.26
0.36
100.00%
-1026.48%
-1026.48%
--
-879.02%
-879.60%
$-283.64M
--
--
--
0.01
--
--
--
-6.76%
-6.76%
-4.36%
-4.99%
$17.02
$-2.93
$-2.92